EligibleTrials

Clinical trials recruiting for HR+/HER2- Ductal and Lobular Breast Cancer

Fewer than 3 recruiting trials found.

2
Recruiting trials
8
US states with sites
12
Countries
0%
Accept healthy volunteers

Phase breakdown

Phase 1 2

Drugs and treatments being studied

InterventionTrials
177Lu-DFC4131
68Ga-NNS3091
[177Lu]Lu-NNS3091
[68Ga]Ga-NNS3091

Where trials are recruiting (top US states)

StateRecruiting trials
Alabama1
California1
Florida1
Massachusetts1
Michigan1
Minnesota1
Texas1
Washington1

Top cities

Birmingham, Alabama 1Boston, Massachusetts 1Grand Rapids, Michigan 1Houston, Texas 1Jacksonville, Florida 1Los Angeles, California 1Palo Alto, California 1Rochester, Minnesota 1Seattle, Washington 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for HR+/HER2- Ductal and Lobular Breast Cancer often also study these conditions. Each links to its own recruiting-trial list.

Triple-negative breast cancer 138Pancreatic Ductal Adenocarcinoma 64Pancreatic cancer 870Non-small cell lung cancer 507Lung cancer 2180Colorectal cancer 1359Soft Tissue Sarcoma 14Breast cancer 2239

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for HR+/HER2- Ductal and Lobular Breast Cancer trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.